glp 1 agonist or antagonist Classification of currently available glucagon-like peptide-1 receptor glp-1_analogs [TUSOM | Pharmwiki]

2023;63(4S):s25-s30

GLP-1s for Alcohol Use Disorder (AUD) Early research has included investigations to determine whether GLP-1 might be an effective treatment for AUD

KFF research found that 54% of adults who have taken GLP-1 drugs reported difficulty affording the therapy, with 22% stating it was very difficult. Geographic disparities: Patients in rural or underserved areas tend to face significant disparities in accessing GLP-1 therapies

A 2023 JAMA study associates GLP-1 agonists with an increased risk of several conditions, including gastroparesis

Why it works: GLP-1 levels typically plateau around 90 days

Weight loss and heart failure: A nationwide study of gastric bypass surgery versus intensive lifestyle treatment